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Abstract 
Coccidioidomycosis (CM) is a disease of major public health importance due to the challenges in its diagnosis and 
treatment. To understand CM requires the attributes of a multidisciplinary network analysis to appreciate the complexity 
of the medical, the environmental and the social issues involved: public health, public policy, geology, atmospheric 
science, agronomy, social sciences and finally humanities, all which provide insight into this population transformation. 
In section 1 of this paper, we describe the CM-epidemiology, the clinical features, the diagnosis and finally the 
treatment. 
In section 2, we highlight the most important contributions and controversies in the history of the CM-research by using 
scientometric or bibliometric evaluations of research that are based on Garfield’s work (Garfield.library.upenn.edu) on 
the propagation of scientific thinking.  
Keywords: Coccidioidomycosis, Valley Fever, epidemiology, fungal infection, disseminated, azoles, bibliometrics, 
spatio-temporal analysis 
1. Coccidioidomycosis: A Medical Perspective 
1.1 Introduction 
The genus Coccidioides consists of two species: C. immitis and C. posadasii.  
Initially it was believed that C. immitis was a species that existed only in California, while C. posadasii was the 
predominant species everywhere else. However, now it has been proven that there is considerable overlap in the 
geographical distribution of both species. Nonetheless, they are identical in their clinical presentation and management 
(Twarog, et al., 2015).  
Coccidioides spp. was initially thought to be a protozoan that caused severe disease; the original name for this 
pathogenic fungus was Coccidioides immitis (from the Latin Coccidia protozoan and immitis ―not mild‖). Later on, was 
classified as a dimorphic fungus from the family Onygenaceae.  
The life cycle of this fungus includes a pathogenic phase, characterized by a structure called spherule that originates 
from an inhaled (rarely inoculated trans dermally) arthroconidia, a saprophyte structure that develops in the 
environment. A mycelium form that matures into alternating arthroconidia characterizes the environmental phase. Once 
the arthroconidia are inhaled into the host lungs, it will transform into a spherule that as it matures develops endospores 
completing the life cycle. The pressure generated by the increasing number of endospores eventually ruptures the wall 
of the spherule, and the endospores spread to neighboring tissues, maturing, in turn, to become spherules with the 
subsequent progressive repetition of the cycle. The majority of ascomycete fungi are strictly saprotrophic, but 
Coccidioides spp. has developed the ability to infect mammals including humans.  
Both Coccidioides species grow in arid to semiarid alkaline soils in the Western United States, Northern Mexico, 
isolated regions of Central and South America. Most isolates of Coccidiodes spp. have been recovered 10-30 cm. 
beneath the soil surface (Fisher, et al., 2007).  
There is a hypothesis that Coccidioides spp. responds to moisture in the soil. After the seasonal rains the fungus grows 
as mycelium and when the soil dries out or nutrients become limiting, the fungus reproduces asexually by 
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disarticulating the hyphae into arthroconidia. These are easily aerosolized when wind currents or human activities 
disturb the soil (Hector, et al., 2011; Tamerius, 2011). It has been reported in Arizona that low precipitation seasons 
correlate with a higher incidence of primary CM.  
1.2 Epidemiology  
The incidence of reported CM in the United States in the past twenty years has increased greatly. It is a disease of major 
public health importance due to the challenges in its diagnosis and treatment (McCotter, et al., 2019).  
The hyperendemic regions in the United States are the Central Valley of California and Southern Arizona; most cases 
(>95%) are reported in those two states. In 2016, California reported a record number of cases (Cooksey, et al., 2017). 
About 1-2% of the cases in the United States are reported in Nevada, New Mexico, and Utah.  
The increase in the number of cases is multifactorial. For example in Arizona, there has been a 75% increase in the 
population from 1990 to 2010 in part due to migration, with people likely to be immune-naïve to CM; as a result of this 
expansion in the population, there has been also an increase in the development of suburban areas of desert type in the 
Phoenix and Tucson metropolitan areas, with the consequent removal of the soil and increase in the exposure of dust in 
the air (McCotter, et al., 2019).  
CM is the most prevalent of the systemic mycosis in Mexico and infection is as prevalent as in the endemic regions of 
the United States (Ajello, 1967). Baja California, Coahuila, Sonora, and Nuevo Leon have reported the highest rates of 
infection in Mexico. The endemic regions in Mexico, like in the United States, are characterized by a dry climate, 
alkaline soil, and summers with temperatures as high as 50°C and very low annual precipitations. All these 
environmental factors favor the presence of Coccidioides and its spread through air currents (Laniado-Laborin, 2006).  
The prevalent species in Mexico is C. posadasii (Bialek, et al., 2004), although C. immitis has been also isolated in the 
northwestern states.  
The clinical burden of disease in Mexico is currently unknown (Castañon-Olivares, et al., 2004). CM was a reportable 
disease in Mexico up to 1994, with an average then of 1,500 cases per year (Baptista-Rosas, et al., 2007).  
Information about CM in Central America is scarce and autochthonous human cases have been reported in Guatemala 
and Honduras (Castro, et al., 1951; Perez-Guisasola et al., 1960; Garcia-Valdez, et al., 1960). Cases are reported 
sporadically in Honduras while in Guatemala an average of 6 cases of CM is reported annually, mostly in HIV-infected 
individuals. Based on the results of skins surveys with coccidioidin, more cases should be expected in the region, but 
lack of awareness of the disease and the absence of equipped laboratories for mycological diagnosis contribute to its sub 
diagnosis. The predominant species in Guatemala is C. posadasii, although C. immitis can also be isolated in the region 
(Engelthaler, et al., 2016).  
CM incidence in South America is unknown for several reasons: it is not a reportable disease, there is little awareness of 
the disease and it might be misdiagnosed as tuberculosis, which is also endemic and more frequent in the region. As in 
other regions, CM in South America is endemic in arid and semiarid areas with alkaline soil and extreme temperatures, 
with cases being reported in Colombia, Venezuela, Brazil, Paraguay, Bolivia and Argentina (Laniado-Laborin, et al., 
2019).  
Although all those exposed can be infected, there are certain risk factors for developing severe forms of 
Coccidioidomycosis. African Americans, Filipinos, pregnant women, and immunosuppressed patients have a higher 
risk of dissemination (Odio, et al., 2017).  
Certain occupational exposures such as working in construction, agricultural or archeological work has been associated 
with a higher risk of exposure and disease (Freedman, et al., 2018; Kollath, et al., 2019). Diabetes is an important risk 
factor for CM in Mexico. The country has one of the highest rates of diabetes in the world (9.4%) and severe forms of 
CM have been reported in diabetics for more than 30 years (Forsbach-Sanchez, et al., 1985).  
In the United States incidence of CM increases steadily with age, with subjects >70 years having the highest rate 
reported at 209 cases per 105 population while the rate for those between 1 and 4 years of age is only 7.7 per 105 
population (McCotter, et al., 2019).  
1.3 CM Clinical Features 
About 60% of individuals exposed to CM will develop an asymptomatic and self-limited infection and would only 
know that they have been infected if tested with coccidioidin/spherulin or through serology assays.  
The remaining 40% will develop an infection with variable clinical features. Most will develop a primary pulmonary 
infection, known as Valley Fever, characterized by pneumonia, pleuritic pain/pleural effusion, arthralgia, joint swelling 
and different types of skin rashes, including erythema nodosum. In the vast majority of patients, this acute syndrome 
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will be self-limited, sometimes leaving a lung cavity as a sequela. Within the endemic regions, a significant proportion 
(up to a 20-30%) of community-acquired pneumonia correspond to primary coccidioidal pneumonia (Sunenshine, et al., 
2007).  
In 5% of the cases, CM will progress to chronic fibrocavitary lung disease or will disseminate (<1% of infections), 
involving the skin, bones/joints, the central nervous system, and other organ systems. The most serious form of CM is 
the meningeal infection, which occurs in less than 1% of extrapulmonary cases (Hector, et al., 2005 ; Laniado-Laborin, 
2006).  
In endemic regions for tuberculosis and CM, like in northern Mexico, both diseases may coexist. They share 
epidemiological, clinical, and radiographic and histopathology features, which may complicate the diagnosis; the 
diagnosis of one of them does not exclude the existence of the other (Castañeda-Godoy, et al., 2002).  
1.4 Diagnosis 
There are several methods by which CM may be diagnosed. The isolation of Coccidioides spp. in culture is the gold 
standard for diagnosis. The fungus can be recovered in culture from tissues, sputum and body fluids. Isolation of 
Cocidioides spp. from any site is diagnostic of the disease. Cocidioides spp. does not need special culture media, 
although the preferred media is Saboraud agar. It grows in 3-5 days, producing highly infectious arthroconidia, which 
represent a significant risk to laboratory personnel; all specimens from a patient with the potential diagnosis of CM 
should be processed under biosafety level 3 conditions.  
The identification of the typical 20-80 μm spherules on sputum smears or in pathologic specimens (stained with 
periodic acid-Schiff or Gomori methenamine silver) also is considered confirmatory of CM; tissues will usually 
demonstrate a chronic granulomatous inflammatory reaction, very similar of that of tuberculosis (Twarog, et al., 2015).  
There are several serological tests available for the diagnosis of CM. These include tube precipitin (TP), complement 
fixation (CF), immunodiffusion, latex particle agglutination (LPA) and enzyme-linked immunosorbent assays (ELISA). 
Immunodiffusion and CF are the most specific serology methods. They are based on the identification of IgM and IgG 
antibodies to the fungal antigens. In the acute phase of the primary infection, almost 50% of the patients will have 
detectable IgM antibodies within the first week and 90% will have antibodies by the third week; these will become 
negative by the third month. Conversely IgG becomes detectable within 1-3 months of initial infection and persists for 
months or even years. The quantitative results of CF are useful to determine disease severity and response to treatment 
(Parish, et al., 2008). LPA, like TP, detects primarily IgM. A serological ELISA method based on the detection of both 
IgM and IgG show high specificity and sensitivity (98.5 and 95.5% respectively) and is commonly used for diagnosis. 
An alternative strategy is to detect fungal antigens (usually in serum) through an antigen enzyme immunoassay; one 
example would be the detection of Coccidioides spp. galactomannan, although there are reports of cross-reactions with 
another mycosis (de Aguiar Cordeiro, et al., 2013).  
Commercial molecular assays are available, based on real-time PCR methods; detection and genotyping of both C. 
immitis and C. posadasii relies on sequencing rDNA.  
1.5 Treatment 
The primary pulmonary disease frequently does not require antifungal therapy while extrapulmonary and disseminated 
disease will usually require prolonged treatment (Ampel, 2015). Current guidelines recommend treatment of 
immunosuppressed patients, those with significant comorbidities, chronic cases and patients with CF titers ≥1: 32 
(Galziani, 2016).  
Some experts recommend treatment of primary pulmonary disease in African American or Filipino patients, given the 
more frequent severe presentation of the disease in these ethnic groups. Other situations where experts recommend 
treatment are patient with extensive pneumonia and prominent hilar adenopathy (Galziani, 2000).  
The first effective drug for the treatment of CM was amphotericin B but due to the need of prolonged intravenous 
administration and significant toxicity, it has been replaced with azole drugs (itraconazole, fluconazole, voriconazole, 
posaconazole, and isavuconazole). Fluconazole (90%), voriconazole (96%) and isavuconazole (98%) have excellent 
oral bioavailability while itraconazole (55%) and posaconazole (54%) have poor oral bioavailability (Thompson, 2019).  
An exception for the use of azoles is pregnancy during the first trimester due to the teratogenicity of azoles. 
Amphotericin B (lipid formulation is preferred) is the drug of choice in this population (Thompson, 2019). Azoles can 
replace amphotericin after the first trimester to avoid prolonged intravenous therapy and toxicity (Bergovitch, 2011).  
Fluconazole is the drug of choice for the treatment of meningeal disease due to its better penetration (60%) into the 
cerebrospinal fluid (CSF). The dose can range from 400 to 800 mg, but doses as high as 2,000 mg have been used 
(Johnson, 2006); itraconazole and posaconazole do not penetrate into the CSF, while voriconazole penetration in CSF is 
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only 50%.  
Duration of therapy varies according to the disease site and severity. Primary pulmonary disease, if treated, usually 
requires treatment for less than six months. Meningeal CM, on the other hand, requires lifelong treatment given the high 
relapse rates reported when therapy is discontinued (Blair, 2009).  
A well-known fact that patients who recover from CM have prolonged immunity to reinfection. This would suggest an 
important role for a vaccine; however, despite extensive work on development, there is no effective vaccine for clinical 
use to date (Pappagianis, 2001).  
2. Cocidioidomycosis: A Spatio-Temporal Perspective 
Coccidioidomycosis (CM) is a disease of major public health importance due to the challenges in its diagnosis and 
treatment. To understand CM requires the attributes of a multidisciplinary network analysis to appreciate the complexity 
of the medical, the environmental and the social issues involved: public health, public policy, geology, atmospheric 
science, agronomy, social sciences and finally humanities, all of which provide insight into this population 
transformation (Smith, 1940; Fiese, 1958; Hirschmann, 2007; CDC, 2001; Galgiani, 2005 & 2008); Pappagianis and 
Einstein, 1978; Sprigg et al., 2008 & 2012 & 2014; Sarafoglou and Kafatos, 2013; IPCC, 2007; Hospenthal, 2013; Gia, 
2014; and Deresinski and Mirels, 2019). 
In section 2 of this paper, we highlight the most important contributions and controversies in the history of the 
CM-research by using scientometric or bibliometric research evaluations that are based on Garfield’s work 
(Garfield.library.upenn.edu) on the propagation of scientific thinking. (Garfield initiated the old ―Science Citation 
Index‖, the forerunner of the modern equivalent ―Web of Science‖ database). 
The study of CM is multi-disciplinary, with scientific and humanitarian concerns. Yet, poor communication both 
between and within disciplines is a recognized challenge today.  
There are many scientometric or bibliometric databases, e.g. Google Scholar, PubMed/Medline, CrossRef, Web of 
Science, etc. Our bibliometric analysis of CM-research is based on Web of Science (WoS) database for the period 
1938-2017 /1/. Our sample consists of 2,188 items.  
WoS has two advantages: 
1. It has a long data period. 
2. It has a better classification system than the other databases e.g. Google Scholar. 
2.1 The Spatio-Temporal Distribution of the CM-Research 
The first 80 publications years of CM research by record count are shown in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The first 80 publications years of CM research by record count 
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In Figure 1, the significant increase in published works during this period can be observed. There are two important 
evolutions for scientific creativity during this long period 1938-2017: 
1. Garfield’s scientometric or bibliometric evaluations of research. Merton (1968), de Sola Price (1976) and 
Zuckerman (1987) extended Garfield’s ideas with the ―Matthew effect‖ and the complex problem of 
intellectual influence. 
2. The diffusion of the Internet changed the accessibility of scientific publications. The accessibility of scientific 
publications is more efficient in the last years (Sarafoglou, et al., 2012). 
According to the Web of Science data during the first period of CM- research, namely 1938-1978, the publication rate 
was low. The eponymous publications of the first period generated sufficient dynamics for new citations in the next 
forty years.  
An interesting observation is a CM-research distribution between geographical areas and countries. One should expect 
North America, Central America, and South America are the most prolific areas, because of the spatial configuration of 
CM.  
Highly endemic areas for coccidioidomycosis include California’s San Joaquin Valley, and south and east along a broad 
swath of territory along both sides of the US-Mexico border, through Central America and deep into South America 
(Laniado-Laborin, 2007). Overall, even today throughout the endemic region, cocci surveillance is poor. Yet, some 
statistics give us an idea of the seriousness of the disease. On average, 150,000 people in the U.S. are estimated to 
contract valley fever annually where, between 1990 and 2008, an annual average of 161 deaths were attributed to CM. 
Most of these cases are unreported because initial symptoms are not severe and normal resistance prevails over time. 
Most documented cases come from the U.S. state of Arizona where, in 2007, approximately 3000 cases were reported 
(there were 6000 cases reported nation-wide), with an associated 1735 hospital visits and $86 million in hospital 
charges (ADHS, 2007; ADHS, 2012).   
In California, Pappagianis (1994) documented increases in CM cases from 1991 to 1993, Huang, (2012) and 
Sondermeyer, et al., (2013) found an average of 70 deaths each year from CM between 1997 and 2008. Medical records 
for Kern County, California, attribute approximately $45 million in direct costs for hospitalization and outpatient care 
for CM-cases during the period 1991–1993 (CDC, 1994). And, Kern County shares much of the San Joaquin Valley.  
Physicians in the US required to report a diagnosed case of CM after 1997. Also, methods of laboratory blood tests for 
cocci have changed over time, and the time-dependent record of surveillance for CM is poor (Sprigg, et.al., 2014).  
In the next Table 1 we may note the actual research distribution of countries by record count. 
 
Table 1. The most prolific countries in the CM-research 
USA (1,482)              
Mexico (68) 
Brazil (58) 
Germany (32) 
Canada (27) 
France (25) 
Argentina (24) 
England (20) 
Japan (14) 
Italy (14) 
 
The USA is the dominant country in the publication of CM-research. Mexico and Brazil are the most prolific countries 
with Spanish or Portuguese language. 
English is the modern "lingua franca" for scientific production (Sandelin and Sarafoglou, 2004). The quantity and the 
quality of the American Universities could be a major explanation too. 
It turns out that there is a tendency for a higher publication rate for English-language countries, slightly lower for 
countries with small languages, and even smaller for countries with large non-English languages. This is consistent with 
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the hypotheses that there is a bias in the databases from the ISI such that English-language journals tend to be 
overrepresented, that scholars from English-language countries write almost exclusively in English, and that scholars 
from other countries tend to publish less in English and more in their domestic language the larger their domestic 
language. This calls for caution in using these databases for international comparisons of research activity. 
One of the outliers in Table 2 is Germany. Germany is not connected geographically with the CM-regions, but Germany 
has produced more publications than endemic countries, e.g. Argentina. 
The explanation might be the educational background of the Argentinian student Alejandro Posadas. He was the first 
author of CM-research. He wrote, ―Un nuevo caso de micosis fungoide con psorospermias‖ (1892). Posadas studied in 
Buenos Aires, and his professor Roberto Wernicke was another Argentinian with German parents. Wernicke studied at 
Jena University in Germany, and he became a professor in Buenos Aires after his return to Argentina. 
He published an article (1892) after Posadas’ publication for CM with the title ―Über einen Protozoen befund bi 
Mykosis Fungoides‖. This article generated a new scientific research in Germany (Sarafoglou, et al., 2012).  
There are two other prominent CM-researchers who studied or were born in Germany: 
1. William Ophüls 
William was born in Brooklyn, but he went to study in Germany. He returned to US after his studies at 
Würzburg and Göttingen, and he became a professor in California some years later. 
2. Hans E. Einstein  
Einstein was born in Berlin and he emigrated from Germany to the USA via Holland during Hitler’s early 
period at age 16. He was an Albert Einstein’s relative. He got a medical degree from New York Medical 
College. He was active in California too. 
The first North American CM-article was published by Emmett Rixford and TC Gilchrist (1986). Fiese (1958) wrote 
that this paper ―was the first extensive study of CM and the first in which the significance of the parasite, as the agent of 
the new and disease, was appreciated.‖ 
But Table 1 is a manifestation of international cooperation and the migration of researchers. 
2.2 The Publications 
Another interesting question is the distribution of Science Categories of the CM-research. 
In the next Table 2 this distribution is depicted: 
 
Table 2. The distribution of Science Categories and Source Titles of the CM-research 
Infectious Diseases (515) 
Medicine General Internal (349) 
Immunology (349) 
Microbiology (328) 
Mycology (229) 
 
We can observe that the category Infectious Diseases is the most dominant Science Category. In order to understand 
better the distribution of Science Categories of CM-research, we may look at the distribution of Source Titles: 
 
Table 3. The distribution of Source Titles of the CM-research 
                Clinical Infectious Diseases (105) 
                Infection and Immunity (56) 
                American Review of Respiratory Disease (50) 
                Mycopathologia (42) 
                Chest (41) 
 
A journal for ―clinical infectious diseases‖ has published most of the CM-articles. 
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There is an overlapping between Table 2 and Table 3: 
Namely, the terms ―infectious diseases‖ and ―mycology‖ are common in both Tables. 
2.3 The Significant Authors, Editors and Organizations 
Our database can provide information to estimate the most prolific authors and the most citated authors of the 
CM-research. 
The most prolific authors are in order in Table 4: 
 
Table 4. Prolific Authors in Terms of Publications 
Pappagianis D (94) 
Galgiani JN (89) 
Stevens DA (84) 
Ampel NM (77) 
Blair JE (63) 
 
Charles Smith’s epigone Demosthenes Pappagianis has been studied at Stanford and Berkeley and now works at 
UC-Davis. He is one of the oldest and the most productive CM-researchers in the world (90+ years old).  
John Galgiani works at the University of Arizona. 
 Editors are also important in the scientific diffusion of the CM-research. In Table 5 the most important editors are 
evaluated: 
 
Table 5. Editors 
Einstein HE (39) 
Clemons KV (37) 
Stevens DA (36) 
Laniado-Laborin R (36) 
 
It seems that the four most important editors have almost equal production. 
The next Table 6 depicts the organizations with the number of publications. 
 
Table 6. Organizations 
University of California System (369) 
University of Arizona (244) 
University of California-Davis (138) 
Mayo Clinic (106) 
Stanford University (100) 
 
The two CM-infected states in the US are also the most productive in research: California and Arizona. Stanford and 
UC-Berkeley have a historical value-added of research per se within the California state. Davis was once the 
agricultural college of Berkeley. However, when Davis became independent of Berkeley, a group of CM-scholars 
(Pappagianis and others) moved from Berkeley to Davis with their laboratory. This is the explanation of the high 
productivity of UC-Davis. The citation is an index of research impact. The most cited authors of the CM-research are 
written in Table 7. 
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Table 7. Citations 
Wallis RS et al. (2004) ……………………………………..531 
McNeil MM et al. (1998) …………………………………...432 
...................................................................................... 
Galgiani JN et al. (2005)……………………………………287 
Zwirewich, CV et al. (1991) ………………………………..261 
Drutz DJ (1978) ……………………………………………..257 
 
The first two articles are Conference Articles, and the other articles are Journal Articles. The citation is an index of the 
research impact. Galgiani is one of the most prolific and cited authors. He might verify the ―Matthew effect‖ in the 
CM-research (Merton, 1968): 
―A macroscopical version of the Matthew principle is apparently involved in those processes of social selection that 
currently lead to the concentration of scientific resources and talent. ― 
2.4 The Financing of CM-Research 
Finally, the financing of CM-research is a vital and complex question which affects the entire subject area. There are 
major differences between regions: North America vs. Latin America, America vs. Europe, Germany vs. other EU-states, 
etc.  
The medical control system of a country to produce a new medicine is extremely important too. The form of 
longitudinal studies (number of patients and the number of years) can increase the costs of the new medicine. 
Yet, research shows that a vaccine is, indeed, possible (Cole, et al., 2004; Galgiani, 2008) and perhaps a change in the 
conventional business model for vaccine development should be modified, as Galgiani suggests.  
          “The industry had been slow to invest, with prior outbreaks limited in scale and a virus believed confined 
within poor countries.‖     
We may expect that the Funding Agencies based in the US will be the dominant agencies in the international market.  
 
Table 8. Funding Agencies 
NIAID NIH HHS (84) 
Pfizer (16) 
NIH (9) 
Astellas (9) 
Merck (8) 
 
The National Institutes of Health (NIH) finance more CM-projects than the private companies. There is no available 
information in our sample for the money value of these projects. 
It may take an international partnership between industry and governments to solve or significantly reduce the problem 
of CM, mutually investing in risk avoidance measures, to ―promote the general welfare,‖ a purpose of government, as 
the preamble to the U.S. Constitution states. Long-term views are needed, a higher quality of government, as important 
questions arise because the cocci fungus is so linked to the variability of weather and future climates – and to how 
society responds (Sarafoglou et al., 2016). Will deserts and the range of CM expand or ―migrate‖ to unsuspecting 
populations? Employment in solar energy fields has become a new, high-risk occupation for CM in this growing 
industry will new ―migrant‖ workers from non-endemic areas be especially vulnerable?  
Recently, Deresinski and Mirels, (2019) wrote: 
―The search for the ―Holy Grail‖ - a vaccine capable of preventing this disease-continues‖.  
Epilogue 
The CM-research is a multidisciplinary research. Geology, Atmospheric Sciences, Medicine and Public Health are the 
main disciplines. The higher interaction of these disciplines could generate a more effective CM-treatment. In other 
words, the complexity of the CM-research needs a holistic (transdisciplinary) approach. 
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Another older philosophical explanation of CM-research interpretation with respect to publications and citations by 
scholars might be similar to Plato’s ―Allegory of the Cave‖ in his ―Republic.‖ According to this allegory, prisoners 
isolated in a cave with limited lighting could see the shadows of the objects and tried to identify them (Baggott, 2011). 
This allegory symbolizes the constraints of human knowledge in relation to the actual reality.  
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